메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
출처
Springer Science and Business Media LLC Scientific Reports 14(1)
오류 신고하기
표지

검색

    초록·키워드

    A weak correlation between diffusing capacity of the lung for carbon monoxide (DL<sub>CO</sub>) and emphysema has been reported. This study investigated whether impaired DL<sub>CO</sub> in chronic obstructive pulmonary disease (COPD) is associated with increased risk of acute exacerbation independent of the presence or extent of emphysema. This retrospective cohort study included patients with COPD between January 2004 and December 2019. The participants were divided into four groups based on visually detected emphysema and impaired DL<sub>CO</sub>. Among 597 patients with COPD, 8.5% had no emphysema and impaired DL<sub>CO</sub> whereas 36.3% had emphysema without impaired DL<sub>CO</sub>. Among the four groups, patients with impaired DL<sub>CO</sub> and emphysema showed a higher risk of moderate-to-severe or severe exacerbation than those with normal DL<sub>CO</sub>. Impaired DL<sub>CO</sub> was an independent risk factor for severe exacerbation (hazard ratio, 1.524 [95% confidence interval 1.121-2.072]), whereas the presence of emphysema was not. The risk of moderate-to-severe or severe exacerbation increases with the severity of impaired DL<sub>CO</sub>. After propensity-score matching for the extent of emphysema, impaired DL<sub>CO</sub> was significantly associated with a higher risk of moderate-to-severe (p = 0.041) or severe exacerbation (p = 0.020). In patients with COPD and heterogeneous parenchymal abnormalities, DL<sub>CO</sub> can be considered an independent biomarker of acute exacerbation.

    본문·목차

    최근 본 자료 전체보기